Research article
Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer
Kathleen I. Pritchard, Humaira Khan, Mark Levine and The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
CMAJ April 16, 2002 166 (8) 1017-1022;
Kathleen I. Pritchard
Dr. Pritchard is Head of Clinical Trials and Epidemiology, Toronto Sunnybrook Regional Cancer Centre, and Professor in the Department of Medicine, University of Toronto, Toronto, Ont.; Ms. Khan is Research Assistant, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. Penny Barnes, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Beverley Carter, Hamilton Health Sciences, Henderson General Hospital, Hamilton, Ont.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmonton, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Jennifer Van Koeveringe (Health Canada), Cancer Division, Centre for Chronic Disease Prevention and Control, Health Canada, Ottawa, Ont.; and Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.
Humaira Khan
Dr. Pritchard is Head of Clinical Trials and Epidemiology, Toronto Sunnybrook Regional Cancer Centre, and Professor in the Department of Medicine, University of Toronto, Toronto, Ont.; Ms. Khan is Research Assistant, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. Penny Barnes, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Beverley Carter, Hamilton Health Sciences, Henderson General Hospital, Hamilton, Ont.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmonton, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Jennifer Van Koeveringe (Health Canada), Cancer Division, Centre for Chronic Disease Prevention and Control, Health Canada, Ottawa, Ont.; and Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.
Mark Levine
Dr. Pritchard is Head of Clinical Trials and Epidemiology, Toronto Sunnybrook Regional Cancer Centre, and Professor in the Department of Medicine, University of Toronto, Toronto, Ont.; Ms. Khan is Research Assistant, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. Penny Barnes, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Beverley Carter, Hamilton Health Sciences, Henderson General Hospital, Hamilton, Ont.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmonton, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Jennifer Van Koeveringe (Health Canada), Cancer Division, Centre for Chronic Disease Prevention and Control, Health Canada, Ottawa, Ont.; and Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.
Dr. Pritchard is Head of Clinical Trials and Epidemiology, Toronto Sunnybrook Regional Cancer Centre, and Professor in the Department of Medicine, University of Toronto, Toronto, Ont.; Ms. Khan is Research Assistant, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. Penny Barnes, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Beverley Carter, Hamilton Health Sciences, Henderson General Hospital, Hamilton, Ont.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmonton, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Jennifer Van Koeveringe (Health Canada), Cancer Division, Centre for Chronic Disease Prevention and Control, Health Canada, Ottawa, Ont.; and Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.
Data supplements
Également disponible :
Related Articles
- (2002). Highlights of this issue. CMAJ, 166(8), 1009. Accessed August 04, 2024. Retrieved from http://www.cmaj.ca/content/166/8/1009.
In this issue
Article tools
Respond to this article
Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer
Kathleen I. Pritchard, Humaira Khan, Mark Levine, The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
CMAJ Apr 2002, 166 (8) 1017-1022;
Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer
Kathleen I. Pritchard, Humaira Khan, Mark Levine, The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
CMAJ Apr 2002, 166 (8) 1017-1022;